Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1998-10-5
pubmed:abstractText
There is no effective therapy against hormone refractory prostate cancer. This led us to evaluate the effectiveness and toxicity of cis-platinum (CDDP) and ifosfamide (IFM) combination chemotherapy in the patients with hormone-unresponsive carcinoma of the prostate.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0021-5287
pubmed:author
pubmed:issnType
Print
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
657-64
pubmed:dateRevised
2011-7-28
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
[Combination chemotherapy with cis-platinum and ifosfamide for hormone unresponsive prostate cancer].
pubmed:affiliation
Department of Urology, Okayama University Medical School, Japan.
pubmed:publicationType
Journal Article, English Abstract, Review